Skip to main content
. 2015 Dec 18;7(14):18558–18572. doi: 10.18632/oncotarget.6670

Figure 5. OBP-401 kills human malignant melanoma cell lines in vitro.

Figure 5

A. Representative images of RFP-expressing human malignant melanoma cell lines, Mel526-RFP, FEMX1-RFP, LOMVIXI-RFP, and MV3-RFP, 7 days after targeting with OBP-401 at a MOI of 5, 15, and 30. B. Bar graphs show the surviving fraction of Mel526-RFP, FEMX1-RFP, LOMVIXI-RFP, and MV3-RFP cells 7 days after targeting with OBP-401 in vitro. The number of live cells was counted. Data are shown as average ± SD. N = 5. Scale bars = 250 μm.